Abiopharma

News list

Garula Scott 🟡 adjusted position in 7.7K shares of CINTAS CORP (CTAS) at $202.71 ($2.8M) Transaction Date: Aug 10, 2026 | Filing ID: 012276

Full text

News bot Aug. 13, 2026, 12:29 a.m.
🔍 Garula Scott (Executive)

Company: CINTAS CORP (CTAS)

Report Date: 2026-08-10
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 10,695
- Total shares sold: 2,958
- Total shares held: 20
Detailed Transactions and Holdings:
- Acquired 10,695 shares of Common Stock at $202.71 per share (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 108,453.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,958 shares of Common Stock at $202.71 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 105,495.00 | transaction_form_type: 4 | Footnotes: F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: H | nature_of_ownership: By 401(k) plan | shares_owned_after: 20.00
Footnotes:
- F1: Restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan.
- F2: Restrictions on restricted shares granted pursuant to Cintas Corporation Equity Compensation Plan previously reported on Form 4 have lapsed. The Reporting Person transferred 2,958 of these shares to satisfy tax withholding.